Revenue Update on Teleflex Incorporated(NYSE:TFX)

Teleflex Incorporated(NYSE:TFX) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 28, 2016. Company reported revenue of $473.55M. Analysts estimated a revenue of $468.40M. Earnings per share were $1.89. Analysts had estimated an EPS of $1.74.

In a different note, On Jul 12, 2016, KeyBanc said it Downgrades its rating on Teleflex Incorporated. The shares have been rated ‘Sector Weight’ by the firm. On Jun 14, 2016, Barclays said it Maintains its rating on Teleflex Incorporated. In the research note, the firm Raises the price-target to $170.00 per share. The shares have been rated ‘Overweight’ by the firm. On May 2, 2016, Leerink Swann said it Maintains its rating on Teleflex Incorporated. In the research note, the firm Raises the price-target to $153.00 per share. The shares have been rated ‘Market Perform’ by the firm.

Teleflex Incorporated (TFX) shares turned negative on Thursdays trading session with the shares closing down -0.16 points or -0.09% at a volume of 1,67,711. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $180.41. The peak price level was also seen at $180.41 while the days lowest was $179.05. Finally the shares closed at $179.87. The 52-week high of the shares is $183.94 while the 52-week low is $122.13. According to the latest information available, the market cap of the company is $7,921 M.

Several Insider Transactions has been reported to the SEC. On Jun 7, 2016, Stuart A Randle (director) sold 797 shares at $166.10 per share price.Also, On May 18, 2016, Thomas Anthony Kennedy (Senior VP, Global Operations) sold 15,102 shares at $160.20 per share price.On Aug 21, 2015, Patricia C Barron (director) sold 1,500 shares at $132.74 per share price, according to the Form-4 filing with the securities and exchange commission.

Teleflex Incorporated is a provider of medical technology products. The Company designs develops manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company also markets and sells its products to hospitals and healthcare providers. The Company operates its business in six segments: Vascular North America; Anesthesia/Respiratory North America; Surgical North America; Europe the Middle East and Africa (EMEA); Asia and Original Equipment Manufacturer (OEM). The Company manufactures its products at 26 manufacturing sites with manufacturing operations located in the Czech Republic Germany Malaysia Mexico and the United States. The Company’s specialty product line consists of a range of catheters including Foley intermittent external and suprapubic; urine collectors; catheterization accessories and products for operative endourology.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Teleflex Incorporated - Is it time to Sell?

Top Brokerage Firms are advising their investors on Teleflex Incorporated. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.